Is there clinical value to prognostic signatures in early-stage NSCLC? - Wikidata - wikimedia - TriplyDB

Is there clinical value to prognostic signatures in early-stage NSCLC?

Is there clinical value to prognostic signatures in early-stage NSCLC?

http://www.wikidata.org/entity/Q28384571

about

Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer.ROS1 immunohistochemistry among major genotypes of non-small-cell lung cancer Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC).

P2860

Q33679694-8BF03EF0-848D-431A-9EF0-6F25D6339096 Q36629689-A79EAD3C-AAA1-4A79-8DDB-94E2936ECDAE Q39012785-B387A534-D9B6-45B3-9A16-C80A49146B23

P2860

Is there clinical value to prognostic signatures in early-stage NSCLC?

http://www.wikidata.org/entity/Q28384571

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Is there clinical value to prognostic signatures in early-stage NSCLC?

@ast

Is there clinical value to prognostic signatures in early-stage NSCLC?

@en

Is there clinical value to prognostic signatures in early-stage NSCLC?

@nl

type

label

Is there clinical value to prognostic signatures in early-stage NSCLC?

@ast

Is there clinical value to prognostic signatures in early-stage NSCLC?

@en

Is there clinical value to prognostic signatures in early-stage NSCLC?

@nl

prefLabel

Is there clinical value to prognostic signatures in early-stage NSCLC?

@ast

Is there clinical value to prognostic signatures in early-stage NSCLC?

@en

Is there clinical value to prognostic signatures in early-stage NSCLC?

@nl

P1433

Q28384571-10AFCB5C-39F1-4410-92C9-E32FA5FEE7BF

P1476

Q28384571-DDAD2FF2-9BB6-4D87-9B89-6BA42992698A

P2093

Q28384571-33AE3A3D-C5CA-425B-BDCF-D7494AF239D3

Q28384571-6BAEC29D-1F41-4E3E-BC66-EEB916EB40C0

Q28384571-C8F69354-9163-4DBC-80A2-AEF666DCA92A

P2860

Q28384571-23E59A15-D6D2-4399-8992-CF5E39DB6793

Q28384571-3351E234-C518-47B7-A767-62D0F4977775

Q28384571-338EDB0C-B7D6-48ED-BBF3-EDF8CB5C4D0D

Q28384571-3D3AD31D-8984-483D-972C-605E167AB46A

Q28384571-46472656-7AAE-4387-A2B0-4D492E375FB8

Q28384571-4F2DC3D9-3841-48EF-8D2C-2DB5062AABD4

Q28384571-4FD2DA43-0D13-4711-84CF-B956DE976ECE

Q28384571-691FFA23-4A32-4889-AF9E-D4A1694C5C86

Q28384571-79F69FAA-F19E-4368-8ED1-1EA0FF32B892

Q28384571-7E74D1E1-0140-4D0D-AB47-5F591DC9CBEB

P304

Q28384571-7E1559BD-3B2D-4051-AEB6-A68E2FB69561

P31

Q28384571-21B5DE5D-E56F-46F0-B035-304872EC5DFF

P356

Q28384571-8BF6DB33-CB5C-47F3-AB29-404B1419A157

P407

Q28384571-135ADE74-D222-42F1-ADEF-2A94E3B5DBAA

P433

Q28384571-91066481-1548-4D74-8719-A21DF7A0A67E

P478

Q28384571-77049DB0-7486-4B20-8746-6098023E6291

P577

Q28384571-F766A581-AE08-47B7-8CF3-2F2A36C93358

P698

Q28384571-A7C29793-CE8B-466D-8B52-F4C9C33F19C4

P932

Q28384571-241BBEC4-4FAC-4348-A92D-4BFB15EC1640

P356

1078-0432.CCR-13-3387

P1433

Clinical Cancer Research

P1476

Is there clinical value to prognostic signatures in early-stage NSCLC?

@en

P2093

Dara L Aisner

http://www.w3.org/2001/XMLSchema#string

Fred R Hirsch

http://www.w3.org/2001/XMLSchema#string

Paul A Bunn

http://www.w3.org/2001/XMLSchema#string

P2860

Confirmation of gene expression-based prediction of survival in non-small cell lung cancer

Prognostic gene signatures for non-small-cell lung cancer.

Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.

Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis.

A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma

P304

1727-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-13-3387

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24583801

http://www.w3.org/2001/XMLSchema#string

P932

3998101

http://www.w3.org/2001/XMLSchema#string